VSIM Christopher Parrish Diagnosis: Cystic Fibrosis feedback log - Scored 100% (latest 2023)

VSIM Christopher Parrish Diagnosis: Cystic Fibrosis feedback log - Scored 100% (latest 2023) (INCLUDE PATHOPHYSIOLOGY OF DISEASE PROCESS) Cystic fibrosis is a chronic, progressive, inherited, incurable disease affecting exocrine (mucus-secreting) glands. Transmitted as an autosomal recessive trait affecting chromosome 7. The Characterized by major aberrations in sweat gland, respiratory, and pancreatic insufficiency with lungs being the primary organ affected. Causes of signs and symptoms to increase viscosity of bronchia, pancreatic, and mucous gland secretion. NAME OF MEDICATION, CLASSIFICATION, AND INCLUDE PROTOTYPE MEDICATION: Pancrelipase enzymes CLASSIFICATION: Pancrelipase enzymes: digestive agent PROTOTYPE: Pancrelipase enzymes: Enzyme SAFE DOSE OR DOSE RANGE, SAFE ROUTE Adults and children older than age 4: 500 lipase units/kg PO per meal to a maximum of 2,500 lipase units/kg per meal (or 10,000 lipase units/kg per day) or less than 4,000 lipase units/g fat ingested per day. PURPOSE FOR TAKING THIS MEDICATION Exocrine pancreatic secretion insufficiency; cystic fibrosis in adults and children; steatorrhea and other disorders of fat metabolism caused by insufficient pancreatic enzyme